Newly established criteria of insulin, C-peptide, and proinsulin for the diagnosis of endogenous hyperinsulinemic hypoglycemia were derived by ROC analysis in our cohort. The gene discussed is INS; the disease is hyperinsulinemic hypoglycemia.